← Leaderboards
Nikolay V Dokholyan
Pennsylvania State Univ Hershey Med Ctr
$13,663,868
Attributed
$17,878,971
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,878,971 · 13
By mechanism
R01$11,205,076 · 8
R35$4,479,807 · 1
RF1$1,464,036 · 1
R41$656,967 · 1
F32$72,612 · 1
P41$473 · 1
Top collaborators
- Ronald I Swanstrom4 shared
- Richard B Mailman3 shared
- Kent E Vrana3 shared
- Yang Yang3 shared
- Sharon L Campbell2 shared
- Luda Diatchenko2 shared
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsStructureBaseSmall MoleculeDesignMolecularMolecular ConformationPharmaceutical PreparationsMolecular DynamicsLightCellsMediatingMutationPhysiologicalMethodologyBindingSimulationComplexMonitorProgramsPropertyBiologicalPhenotypeCoupled
Grant awards (49)
Nanoscale programming of celluar and physiological phenotypes$659,274
R35 · FY2025 · GM · contact PI
AI-based Mapping of Complex Cannabis Extracts in Pain Pathways$593,686
R01 · FY2025 · AT
Discovery of functionally selective dopamine ligands for age-related cognitive decline$476,375
R01 · FY2025 · AG
Nanoscale programing of celluar and physiological phenotypes$110,983
R35 · FY2025 · GM · contact PI
Nanoscale programing of cellular and physiological phenotypes$738,759
R35 · FY2024 · GM · contact PI
AI-based Mapping of Complex Cannabis Extracts in Pain Pathways$646,457
R01 · FY2024 · AT
Discovery of functionally selective dopamine ligands for age-related cognitive decline$491,923
R01 · FY2024 · AG
Nanoscale programing of cellular and physiological phenotypes$738,759
R35 · FY2023 · GM · contact PI
AI-based Mapping of Complex Cannabis Extracts in Pain Pathways$536,082
R01 · FY2023 · AT
Nanoscale programing of cellular and physiological phenotypes$738,759
R35 · FY2022 · GM · contact PI
Discovery of functionally selective dopamine ligands for age-related cognitive decline$1,464,036
RF1 · FY2021 · AG
Nanoscale programing of cellular and physiological phenotypes$738,759
R35 · FY2021 · GM · contact PI
Nanoscale programming of cellular and physiological phenotypes: Equipment$180,535
R35 · FY2021 · GM · contact PI
Nanoscale programing of cellular and physiological phenotypes$477,979
R35 · FY2020 · GM · contact PI
Nanoscale programing of cellular and physiological phenotypes Equipment$96,000
R35 · FY2020 · GM · contact PI
Engineering allostery for in vivo protein control$444,582
R01 · FY2019 · GM · contact PI
Integrating cheminformatics and molecular simulations for virtual drug screening$235,391
R01 · FY2019 · GM · contact PI
Engineering allostery for in vivo protein control$49,214
R01 · FY2019 · GM · contact PI
Engineering allostery for in vivo protein control$410,687
R01 · FY2018 · GM · contact PI
Integrating cheminformatics and molecular simulations for virtual drug screening$248,768
R01 · FY2018 · GM · contact PI
Engineering allostery for in vivo protein control$78,639
R01 · FY2018 · GM · contact PI
Engineering allostery for in vivo protein control$537,595
R01 · FY2017 · GM · contact PI
Mechanisms of vinculin activation and force transmission$380,388
R01 · FY2017 · GM
Integrating cheminformatics and molecular simulations for virtual drug screening$293,344
R01 · FY2017 · GM · contact PI
Mechanisms of vinculin activation and force transmission$380,388
R01 · FY2016 · GM
Integrating cheminformatics and molecular simulations for virtual drug screening$293,344
R01 · FY2016 · GM · contact PI
Immunogen Design to Target Carbohydrate-Occluded Epitopes on the HIV envelope$497,332
R01 · FY2015 · AI · contact PI
Protein misfolding and aggregation$332,719
R01 · FY2015 · GM · contact PI
Protein misfolding and aggregation$4,906
R01 · FY2015 · GM · contact PI
Immunogen Design to Target Carbohydrate-Occluded Epitopes on the HIV envelope$503,164
R01 · FY2014 · AI · contact PI
Protein misfolding and aggregation$279,122
R01 · FY2014 · GM · contact PI
Protein misfolding and aggregation$34,385
R01 · FY2014 · GM · contact PI
Immunogen Design to Target Carbohydrate-Occluded Epitopes on the HIV envelope$478,299
R01 · FY2013 · AI · contact PI
Development of a Novel Class for Opioid Drugs$320,758
R41 · FY2013 · DA
Protein misfolding and aggregation$269,353
R01 · FY2013 · GM · contact PI
Immunogen Design to Target Carbohydrate-Occluded Epitopes on the HIV envelope$514,331
R01 · FY2012 · AI · contact PI
Development of a Novel Class for Opioid Drugs$336,209
R41 · FY2012 · DA
Protein misfolding and aggregation$279,122
R01 · FY2012 · GM · contact PI
Protein misfolding and aggregation$256,724
R01 · FY2011 · GM · contact PI
Protein misfolding and aggregation$259,317
R01 · FY2010 · GM · contact PI
Protein Misfolding and Aggregation$288,334
R01 · FY2009 · GM · contact PI
Protein misfolding and aggregation$281,771
R01 · FY2009 · GM · contact PI
Error-Prone Replicative Bypass of Platinum Adducts$279,826
R01 · FY2008 · CA · contact PI
Protein misfolding and aggregation$261,936
R01 · FY2008 · GM · contact PI
Protein misfolding and aggregation$27,706
R01 · FY2008 · GM · contact PI
MULTISCALE SIMULATIONS OF BIOMOLECULAR DYNAMICS$473
P41 · FY2008 · RR · contact PI
Protein misfolding and aggregation$259,866
R01 · FY2007 · GM · contact PI
TOWARDS MORE REALISTIC DESIGN OF PROTEINS$40,196
F32 · FY2001 · GM
TOWARDS MORE REALISTIC DESIGN OF PROTEINS$32,416
F32 · FY2000 · GM